Dendritic cells (DCs) are increasingly used as adjuvants for vaccination strategies; however,
there has been very little development in DC vaccines for patients with hepatocellular …

Purpose. To determine the immune response after dendritic cell (DC) vaccine and cytokine-
induced killer cells (CIK) therapy and assess its associated toxicity, survival benefit, and …

Colorectal cancer (CRC) remains a leading cause of cancer-related deaths in the United
States despite an array of available treatment options. Current standard-of-care …

Aim To investigate the efficacy and safety of dendritic cell (DC) vaccine combined with
cytokine-induced killer (CIK) cell therapy in colorectal carcinoma (CRC). Patients and …

2508 Background: We hypothesize that the activity of vaccines based on DC loaded with
tumor antigens will be enhanced by modifications that increase antigen expression and …

Different technologies have been employed to deliver the whole spectrum of tumor antigens
(TAs) to dendritic cells (DCs) to be presented to T cells. These include whole tumor RNA …

For several decades, approaches utilizing nonspecific immune stimulants have provided
evidence that the immune system, when properly activated, may eradicate cancer cells …

Dendritic cells (DCs) are the most potent antigens presenting cells in the immune system.
They have a high capacity to trigger antigen-specific immune responses and promote both …

AIM: To study whether heat-shocked tumor cells could enhance the effect of tumor cell lysate-
pulsed dendritic cells (DCs) in evoking anti-tumor immune response in vivo. METHODS …

The development of effective cancer vaccines depends heavily on the ability to deliver target
antigens to generate an immune response. Dendritic cells are the most potent antigen …